Ray Peat: Links to referenced studies

From Ray Peat Forum Wiki
Revision as of 12:45, 20 December 2015 by Giraffe (talk | contribs) (Created page with "==Emodin== '''Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes.''' <ref>[http://www.ncbi.nlm.nih.gov/pubmed/...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Emodin

Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes. [1]

Abstract

Chronic inflammation of rheumatoid arthritis (RA) is promoted by proinflammatory cytokines and closely linked to angiogenesis. In the present study, we investigated the anti-inflammatory effects of emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) isolated from the root of Rheum palmatum L. in interleukin 1 beta (IL-1β) and lipopolysaccharide (LPS)-stimulated RA synoviocytes under hypoxia. Emodin significantly inhibited IL-1β and LPS-stimulated proliferation of RA synoviocytes in a dose-dependent manner under hypoxic condition. Also, enzyme linked immunosorbent assay (ELISA) revealed that emodin significantly reduced the production of pro-inflammatory cytokines [tumor necrosis factor-alpha (TNF-α), IL-6 and IL-8], mediators [prostagladin E(2) (PGE(2)), matrix metalloproteinase (MMP)-1 and MMP-13] and vascular endothelial growth factor (VEGF) as an angiogenesis biomarker in IL-1β and LPS-treated synoviocytes under hypoxia. Consistently, emodin attenuated the expression of cyclooxygenase 2 (COX-2), VEGF, hypoxia inducible factor 1 alpha (HIF-1α), MMP-1 and MMP-13 at mRNA level in IL-1β and LPS-treated synoviocytes under hypoxia. Furthermore, emodin reduced histone deacetylase (HDAC) activity as well as suppressed the expression of HDAC1, but not HDAC2 in IL-1β and LPS-treated synoviocytes under hypoxia. Overall, these findings suggest that emodin inhibits proinflammatory cytokines and VEGF productions, and HDAC1 activity in hypoxic RA synoviocytes.

full text link



Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. http://www.ncbi.nlm.nih.gov/pubmed/15781642

Effects of emodin treatment on mitochondrial ATP generation capacity and antioxidant components as well as susceptibility to ischemia–reperfusion injury in rat hearts: Single versus multiple doses and gender difference http://www.sciencedirect.com/science/article/pii/S0024320505005370


Effects of pharmacological preconditioning by emodin/oleanolic acid treatment and/or ischemic preconditioning on mitochondrial antioxidant components as well as the susceptibility to ischemia-reperfusion injury in rat hearts

https://www.researchgate.net/publication/7197028_Effects_of_pharmacological_preconditioning_by_emodinoleanolic_acid_treatment_andor_ischemic_preconditioning_on_mitochondrial_antioxidant_components_as_well_as_the_susceptibility_to_ischemia-reperfusio

Effects of emodin on synaptic transmission in rat hippocampal CA1 pyramidal neurons in vitro http://www.sciencedirect.com/science/article/pii/S0028390805000729


Emodin inhibits dietary induced atherosclerosis by antioxidation and regulation of the sphingomyelin pathway in rabbits https://www.researchgate.net/publication/7197028_Effects_of_pharmacological_preconditioning_by_emodinoleanolic_acid_treatment_andor_ischemic_preconditioning_on_mitochondrial_antioxidant_components_as_well_as_the_susceptibility_to_ischemia-reperfusio